1. 681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors. (9th November 2020) Authors: Shaikh, Fyza; White, James; Gills, Joell; Hakozaki, Taiki; Corentin, Richard; Routy, Bertrand; Okuma, Yusuke; Usyk, Mykhaylo; Pandey, Abhishek; Weber, Jeffrey; Ahn, Jiyoung; Naidoo, Jarushka; Lipson, Evan; Pardoll, Drew; Sears, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors. (9th November 2020) Authors: Shaikh, Fyza; White, James; Gills, Joell; Hakozaki, Taiki; Corentin, Richard; Routy, Bertrand; Okuma, Yusuke; Usyk, Mykhaylo; Pandey, Abhishek; Weber, Jeffrey; Ahn, Jiyoung; Naidoo, Jarushka; Lipson, Evan; Pardoll, Drew; Sears, Cynthia Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin–Pemetrexed Therapy for Non-Small Cell Lung Cancer. (26th September 2014) Authors: Takagi, Yusuke; Hosomi, Yukio; Sunami, Kuniko; Nakahara, Yoshiro; Okuma, Yusuke; Yomota, Makiko; Shimokawa, Tsuneo; Nagamata, Makoto; Iguchi, Mari; Okamoto, Hiroaki; Okamura, Tatsuru; Shibuya, Masahiko Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Prospective Study of Shortened Vitamin Supplementation Prior to Cisplatin–Pemetrexed Therapy for Non‐Small Cell Lung Cancer. (26th September 2014) Authors: Takagi, Yusuke; Hosomi, Yukio; Sunami, Kuniko; Nakahara, Yoshiro; Okuma, Yusuke; Yomota, Makiko; Shimokawa, Tsuneo; Nagamata, Makoto; Iguchi, Mari; Okamoto, Hiroaki; Okamura, Tatsuru; Shibuya, Masahiko Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911. Issue 14 (September 2015) Authors: Yamada, Kazuhiko; Aono, Hiromi; Hosomi, Yukio; Okamoto, Hiroaki; Kato, Terufumi; Komase, Yuko; Nishikawa, Masanori; Azuma, Koichi; Takeoka, Hiroaki; Okuma, Yusuke; Nakahara, Yoshiro; Sato, Akira; Oba, Mari S.; Morita, Satoshi; Kunitoh, Hideo; Watanabe, Koshiro Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911. Issue 14 (September 2015) Authors: Yamada, Kazuhiko; Aono, Hiromi; Hosomi, Yukio; Okamoto, Hiroaki; Kato, Terufumi; Komase, Yuko; Nishikawa, Masanori; Azuma, Koichi; Takeoka, Hiroaki; Okuma, Yusuke; Nakahara, Yoshiro; Sato, Akira; Oba, Mari S.; Morita, Satoshi; Kunitoh, Hideo; Watanabe, Koshiro Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1904 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study). (19th May 2020) Authors: Nomura, Shogo; Goto, Yasushi; Mizutani, Tomonori; Kataoka, Tomoko; Kawai, Shoko; Okuma, Yusuke; Murakami, Haruyasu; Tanaka, Kentaro; Ohe, Yuichiro Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 7(2020) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territory. (November 2022) Authors: Kashima, Jumpei; Okuma, Yusuke Journal: Seminars in cancer biology Issue: Volume 86(2023)Part 2 Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer. (February 2022) Authors: Shirasawa, Masayuki; Yoshida, Tatsuya; Imabayashi, Tatsuya; Okuma, Kae; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Tsuchida, Takaaki; Yamamoto, Noboru; Nakayama, Yuko; Watanabe, Shun-ichi; Motoi, Noriko; Ohe, Yuichiro Journal: European journal of cancer Issue: Volume 162(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cellulitis-like symptoms manifested by bone metastasis of lung cancer in a patient living with human immunodeficiency virus. (September 2016) Authors: Kashima, Jumpei; Okuma, Yusuke; Watanabe, Kageaki; Ajisawa, Atushi; Hishima, Tsunekazu Journal: International journal of STD & AIDS Issue: Volume 27:Number 10(2016:Oct.) Page Start: 912 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗